TRxADE Health Inc reports results for the quarter ended in September - Earnings Summary

Scienture Holdings

07/11/2022 22:49

* TRxADE Health Inc  MEDS.OQ  reported a quarterly adjusted
loss
of 6 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 12 cents per share.
    * Revenue fell 5.9% to $2.40 million from a year ago;
analysts
expected $3.30 million. 
    * TRxADE Health Inc's reported EPS for the quarter was a
loss of 6
cents​.
    * The mean earnings estimate of analysts had risen by
about 4% in
the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * TRxADE Health Inc shares had fallen by 25.7% this
quarter and
lost 64.4% so far this year.
    * The company reported a quarterly loss of $528 thousand.
    * Wall Street's median 12-month price target for TRxADE
Health Inc
is $3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
7 at 10:49 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.12          -0.06          Beat
 Jun. 30 2022      -0.08          -0.13          Missed
 Mar. 31 2022      -0.11          -0.12          Missed
 Dec. 31 2021      -0.15          -0.10          Beat